232 related articles for article (PubMed ID: 28842185)
21. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.
Lucas CL; Kuehn HS; Zhao F; Niemela JE; Deenick EK; Palendira U; Avery DT; Moens L; Cannons JL; Biancalana M; Stoddard J; Ouyang W; Frucht DM; Rao VK; Atkinson TP; Agharahimi A; Hussey AA; Folio LR; Olivier KN; Fleisher TA; Pittaluga S; Holland SM; Cohen JI; Oliveira JB; Tangye SG; Schwartzberg PL; Lenardo MJ; Uzel G
Nat Immunol; 2014 Jan; 15(1):88-97. PubMed ID: 24165795
[TBL] [Abstract][Full Text] [Related]
22. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K.
Lucas CL; Zhang Y; Venida A; Wang Y; Hughes J; McElwee J; Butrick M; Matthews H; Price S; Biancalana M; Wang X; Richards M; Pozos T; Barlan I; Ozen A; Rao VK; Su HC; Lenardo MJ
J Exp Med; 2014 Dec; 211(13):2537-47. PubMed ID: 25488983
[TBL] [Abstract][Full Text] [Related]
23. Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype.
Zhao P; Huang J; Fu H; Xu J; Li T; Zhang X; Meng Q; Zhang L; Tan L; Zhang W; Chen H; Lu X; Ding Y; He X
Pediatr Rheumatol Online J; 2024 Jan; 22(1):24. PubMed ID: 38287413
[TBL] [Abstract][Full Text] [Related]
24. E1021K Homozygous Mutation in PIK3CD Leads to Activated PI3K-Delta Syndrome 1.
Wang Y; Chen X; Yang Q; Tang W; Jia Y; Zhou L; An Y; Zhang Z; Tang X; Zhao X
J Clin Immunol; 2020 Feb; 40(2):378-387. PubMed ID: 31953711
[TBL] [Abstract][Full Text] [Related]
25. The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS).
Fekrvand S; Delavari S; Chavoshzadeh Z; Sherkat R; Mahdaviani SA; Sadeghi Shabestari M; Azizi G; Arzanian MT; Shahin Shamsian B; Eskandarzadeh S; Eslami N; Rae W; Condino-Neto A; Mohammadi J; Abolhassani H; Yazdani R; Aghamohammadi A
Immunol Invest; 2022 Apr; 51(3):644-659. PubMed ID: 33401995
[TBL] [Abstract][Full Text] [Related]
26. Mutations in PI3K110δ cause impaired natural killer cell function partially rescued by rapamycin treatment.
Ruiz-García R; Vargas-Hernández A; Chinn IK; Angelo LS; Cao TN; Coban-Akdemir Z; Jhangiani SN; Meng Q; Forbes LR; Muzny DM; Allende LM; Ehlayel MS; Gibbs RA; Lupski JR; Uzel G; Orange JS; Mace EM
J Allergy Clin Immunol; 2018 Aug; 142(2):605-617.e7. PubMed ID: 29330011
[TBL] [Abstract][Full Text] [Related]
27. Activated PIK3CD drives innate B cell expansion yet limits B cell-intrinsic immune responses.
Wray-Dutra MN; Al Qureshah F; Metzler G; Oukka M; James RG; Rawlings DJ
J Exp Med; 2018 Oct; 215(10):2485-2496. PubMed ID: 30194267
[TBL] [Abstract][Full Text] [Related]
28. Activated PI3 Kinase Delta Syndrome: From Genetics to Therapy.
Michalovich D; Nejentsev S
Front Immunol; 2018; 9():369. PubMed ID: 29535736
[TBL] [Abstract][Full Text] [Related]
29. Changes of memory B- and T-cell subsets in lupus nephritis patients.
Kosalka J; Jakiela B; Musial J
Folia Histochem Cytobiol; 2016; 54(1):32-41. PubMed ID: 27094637
[TBL] [Abstract][Full Text] [Related]
30. Activated phosphoinositide 3-dinase delta syndrome (APDS): An update.
Lougaris V; Cancrini C; Rivalta B; Castagnoli R; Giardino G; Volpi S; Leonardi L; La Torre F; Federici S; Corrente S; Cinicola BL; Soresina A; Marseglia GL; Cardinale F
Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):69-72. PubMed ID: 35080319
[TBL] [Abstract][Full Text] [Related]
31. Genetic defects in PI3Kδ affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections.
Wentink M; Dalm V; Lankester AC; van Schouwenburg PA; Schölvinck L; Kalina T; Zachova R; Sediva A; Lambeck A; Pico-Knijnenburg I; van Dongen JJ; Pac M; Bernatowska E; van Hagen M; Driessen G; van der Burg M
Clin Immunol; 2017 Mar; 176():77-86. PubMed ID: 28104464
[TBL] [Abstract][Full Text] [Related]
32. Activated PI3Kδ syndrome type 2: Two patients, a novel mutation, and review of the literature.
Olbrich P; Lorenz M; Cura Daball P; Lucena JM; Rensing-Ehl A; Sanchez B; Führer M; Camacho-Lovillo M; Melon M; Schwarz K; Neth O; Speckmann C
Pediatr Allergy Immunol; 2016 Sep; 27(6):640-4. PubMed ID: 27116393
[TBL] [Abstract][Full Text] [Related]
33. Immunodeficiency due to a novel variant in PIK3CD: a case report.
Shashaani N; Chavoshzadeh Z; Ghasemi L; Ghotbabadi SH; Shiari S; Sharafian S; Shiari R
Pediatr Rheumatol Online J; 2023 Jul; 21(1):71. PubMed ID: 37475052
[TBL] [Abstract][Full Text] [Related]
34. Activated PI3K-delta syndrome in an Egyptian pediatric cohort with primary immune deficiency.
Ahmed AA; El Shahaway AA; Hussien SA
Allergol Immunopathol (Madr); 2020; 48(6):686-693. PubMed ID: 32349894
[TBL] [Abstract][Full Text] [Related]
35. Disseminated and Congenital Toxoplasmosis in a Mother and Child With Activated PI3-Kinase δ Syndrome Type 2 (APDS2): Case Report and a Literature Review of Toxoplasma Infections in Primary Immunodeficiencies.
Karanovic D; Michelow IC; Hayward AR; DeRavin SS; Delmonte OM; Grigg ME; Dobbs AK; Niemela JE; Stoddard J; Alhinai Z; Rybak N; Hernandez N; Pittaluga S; Rosenzweig SD; Uzel G; Notarangelo LD
Front Immunol; 2019; 10():77. PubMed ID: 30891027
[TBL] [Abstract][Full Text] [Related]
36. Cellular Mechanisms Underlying B Cell Abnormalities in Patients With Gain-of-Function Mutations in the
Wang W; Min Q; Lai N; Csomos K; Wang Y; Liu L; Meng X; Sun J; Hou J; Ying W; Zhou Q; Sun B; Hui X; Ujhazi B; Gordon S; Buchbinder D; Schuetz C; Butte M; Walter JE; Wang X; Wang JY
Front Immunol; 2022; 13():890073. PubMed ID: 35799777
[TBL] [Abstract][Full Text] [Related]
37. Human PIK3R1 mutations disrupt lymphocyte differentiation to cause activated PI3Kδ syndrome 2.
Nguyen T; Lau A; Bier J; Cooke KC; Lenthall H; Ruiz-Diaz S; Avery DT; Brigden H; Zahra D; Sewell WA; Droney L; Okada S; Asano T; Abolhassani H; Chavoshzadeh Z; Abraham RS; Rajapakse N; Klee EW; Church JA; Williams A; Wong M; Burkhart C; Uzel G; Croucher DR; James DE; Ma CS; Brink R; Tangye SG; Deenick EK
J Exp Med; 2023 Jun; 220(6):. PubMed ID: 36943234
[TBL] [Abstract][Full Text] [Related]
38. Disorders Related to PI3Kδ Hyperactivation: Characterizing the Clinical and Immunological Features of Activated PI3-Kinase Delta Syndromes.
Redenbaugh V; Coulter T
Front Pediatr; 2021; 9():702872. PubMed ID: 34422726
[TBL] [Abstract][Full Text] [Related]
39. Case Report: EBV Chronic Infection and Lymphoproliferation in Four APDS Patients: The Challenge of Proper Characterization, Therapy, and Follow-Up.
Rivalta B; Amodio D; Milito C; Chiriaco M; Di Cesare S; Giancotta C; Conti F; Santilli V; Pacillo L; Cifaldi C; Desimio MG; Doria M; Quinti I; De Vito R; Di Matteo G; Finocchi A; Palma P; Trizzino A; Tommasini A; Cancrini C
Front Pediatr; 2021; 9():703853. PubMed ID: 34540765
[TBL] [Abstract][Full Text] [Related]
40. Mutations in the adaptor-binding domain and associated linker region of p110δ cause Activated PI3K-δ Syndrome 1 (APDS1).
Heurtier L; Lamrini H; Chentout L; Deau MC; Bouafia A; Rosain J; Plaza JM; Parisot M; Dumont B; Turpin D; Merlin E; Moshous D; Aladjidi N; Neven B; Picard C; Cavazzana M; Fischer A; Durandy A; Stephan JL; Kracker S
Haematologica; 2017 Jul; 102(7):e278-e281. PubMed ID: 28428270
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
